ArticleAnnals of hematology2024

Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal differential expression dynamics on imatinib response in chronic myeloid leukemia.

María Jazmín Toloza et al.PubMed ↗Publisher ↗

No numbers read from the abstract.